Member Societies

• All
• Nov. 16 (Thu)
• Nov. 17 (Fri)
• Nov. 18 (Sat)

• KSG
• KSGE
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Gut and Liver
• Insurance Policy

Symposium 05 : Special issues in colorectal neoplasia prevention, diagnosis, and management English

Date / Time	Nov. 16 (Thu), 09:00-10:20
Room	Grand 4+5
Chair(s)	Dong Il Park (Sungkyunkwan University, Korea) Jonghun Lee (Dong-A University, Korea)
Speakers	09:00-09:20	Recent trend in the epidemiology of colorectal cancer in Korea Soo-Kyung Park (Sungkyunkwan University, Korea)
	09:20-09:40	Crosstalk between microbiome and colorectal neoplasia: early detection and prediction of prognosis Beom Jae Lee (Korea University, Korea)
	09:40-10:00	Serrated polyps: how can we handle with confidence? Hyun Jung Lee (Seoul National University, Korea)
	10:00-10:20	Risk stratification according to the positive fecal immunochemical test and colonoscopic results: who is at risk of interval cancer? Seung Wook Hong (University of Ulsan, Korea)

Symposium 10 : Evidence-based strategies for surveillance and treatment of colorectal tumors English

Date / Time	Nov. 16 (Thu), 10:40-12:00
Room	Grand 4+5
Chair(s)	Tae Il Kim (Yonsei University, Korea) Yutaka Saito (National Cancer Center Hospital, Tokyo, Japan)
Speakers	10:40-11:00	Postpolypectomy colonoscopic surveillance Su Young Kim (Yonsei University Wonju, Korea)
	11:00-11:20	Surveillance and salvage treatment of endoscopically removed T1 colorectal cancer Yutaka Saito (National Cancer Center Hospital, Tokyo, Japan)
	11:20-11:40	Diagnosis and management of colorectal subepithelial lesions Su Bum Park (Pusan National University, Korea)
	11:40-12:00	Treatment and surveillance strategies for rectal neuroendocrine tumor Chang Mo Moon (Ewha Womans University, Korea)

Free Paper 06: Lower GI 01 English

Date / Time	Nov. 16 (Thu), 13:30-14:10
Room	Grand 4+5
Chair(s)	Taeoh Kim (Inje University, Korea) Jong Pil Im (Seoul National University, Korea)
Speakers	13:30-13:40	Forecasting the Future Prevalence of Inflammatory Bowel Disease in Korea through 2048: An Epidemiologic Study Employing Autoregressive Integrated Moving Average Models Jieun Kim (Kyung Hee University, Korea)
	13:40-13:50	Infliximab in Second-Line Biological Therapy for Patients with Crohn's Disease: from Intravenous to Subcutaneous Administration Milan Lukas (Clinical & Research Center for Inflammatory Bowel Disease ISCARE a.s. and Charles University Prague, Czech Republic)
	13:50-14:00	Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure June hwa Bae (University of Ulsan, Korea)
	14:00-14:10	CRP/Albumin ratio in predicting response to steroids in Acute severe ulcerative colitis Aicha Darif (Ibn Rochd University Hospital, Morocco)

Free Paper 07: Lower GI 02 English

Date / Time	Nov. 16 (Thu), 14:10-14:50
Room	Grand 4+5
Chair(s)	Geom Seog Seo (Wonkwang University, Korea) Kang-Moon Lee (The Catholic University of Korea, Korea)
Speakers	14:10-14:20	Real-life effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: An Asan-Crohns and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter cohort study Ji Eun Baek (University of Ulsan, Korea)
	14:20-14:30	Fiber-deficient diet exacerbates immune checkpoint inhibitor-induced colitis in mice with wild microbiota Sung Wook Hwang (University of Ulsan, Korea)
	14:30-14:40	Ten-Year Trend in 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients with Ulcerative Colitis in Korea: A population-based observational study Soo Jung Park (Yonsei University, Korea)
	14:40-14:50	A Retrospective Comparative Study of Therapeutic Responses to Vedolizumab and Ustekinumab in Patients with Moderate to Severe Ulcerative Colitis Seongwon Jo (Seoul National University, Korea)